These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2665175)

  • 1. The measurement of haemostatic factors in 16 European laboratories: quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT).
    Thompson SG; Duckert F; Haverkate F; Thomson JM
    Thromb Haemost; 1989 Apr; 61(2):301-6. PubMed ID: 2665175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of sequential quality assessment exercises on laboratory performance: the multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT).
    Thompson SG; Calori G; Thomson JM; Haverkate F; Duckert F
    Thromb Haemost; 1991 Feb; 65(2):149-52. PubMed ID: 2053100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group.
    Haverkate F; Thompson SG; Duckert F
    Thromb Haemost; 1995 Apr; 73(4):561-7. PubMed ID: 7495059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation.
    Meijer P; Haverkate F
    Semin Thromb Hemost; 2006 Jul; 32(5):485-91. PubMed ID: 16862521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
    Meijer P; Haverkate F; Kluft C
    Thromb Haemost; 2006 Nov; 96(5):584-9. PubMed ID: 17080214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability over time of haemostatic and other cardiovascular risk factors in patients suffering from angina pectoris. ECAT Angina Pectoris Study Group.
    Pyke SD; Thompson SG; Buchwalsky R; Kienast J
    Thromb Haemost; 1993 Nov; 70(5):743-6. PubMed ID: 8128428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis.
    Lowe GD; Haverkate F; Thompson SG; Turner RM; Bertina RM; Turpie AG; Mannucci PM
    Thromb Haemost; 1999 Jun; 81(6):879-86. PubMed ID: 10404761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory performance in the World Federation of Hemophilia EQA programme, 2003-2008.
    Jennings I; Kitchen DP; Woods TA; Kitchen S; Walker ID; Preston FE
    Haemophilia; 2009 Mar; 15(2):571-7. PubMed ID: 19175423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program.
    Hayes TE; Brandt JT; Chandler WL; Eby CS; Kottke-Marchant K; Krishnan J; Lefkowitz JB; Olson JD; Rund CR; Van Cott EM; Cunningham MT
    Semin Thromb Hemost; 2006 Jul; 32(5):499-504. PubMed ID: 16862523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K; Fijnheer R; Rothova A
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
    Haverkate F; Thompson SG; van de Loo JC
    Ann Epidemiol; 1992 Jul; 2(4):521-4. PubMed ID: 1342302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARIC hemostasis study--III. Quality control. Atherosclerosis Risk in Communities.
    Chambless LE; McMahon R; Finch A; Sorlie P; Heiss G; Lyles R; Wu KK
    Thromb Haemost; 1993 Oct; 70(4):588-94. PubMed ID: 8115984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
    Favaloro EJ
    Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.